Snapshot · Russell 3000 · generated 2026-10-16 03:47 UTC

VRTX — Vertex Pharmaceuticals Incorporated

EXPENSIVE (MOS -37.9%) · Quality 78/100

VRTX - Vertex Pharmaceuticals Incorporated
Data generated 2026-10-16 03:47 UTC (nightly scan, universe: Russell 3000).
Price: 508.75 USD
Intrinsic value: 368.81 USD
Margin of safety: -37.9%
Implied growth (reverse DCF): +14.9% (model assumes +9.2%)
Valuation: EXPENSIVE
Value Score: 24.2
Quality: 78/100
Moat score: 59.8 (erosion: watch)
EXPENSIVE (MOS -37.9%) - Quality 78/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/VRTX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

508.75

Intrinsic value

368.81

Margin of safety

-37.9%

Implied growth (reverse DCF)

+14.9%

model assumes +9.2%

Value Score

24.2

Quality

Psychology

7.7

Discovery

20.2

price/volume attention only

Moat score

59.8

erosion: watch

Value Score: bottom 33% of Russell 3000 · Quality: top 15%

Open the interactive Deep Dive for VRTX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/VRTX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is VRTX undervalued?

As of 2026-10-16, VRTX trades at 508.75 against a computed intrinsic value of 368.81 (-37.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Vertex Pharmaceuticals Incorporated's Value Score?

Vertex Pharmaceuticals Incorporated's Value Score is 24.2 as of 2026-10-16 - it combines value, quality, crowd psychology and market attention into one number.